MedTrace Logo

Alive & Thrive Evaluation in Burkina Faso

NCT02435524 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4541

Last updated 2018-12-04

Study results available
· View outcomes & findings →

Summary

The time between birth and age 24 months provides a unique opportunity to impact the long-term health and development of children through improved infant and young child feeding practices. In Burkina Faso, the prevalence of exclusive breastfeeding is currently around 25% in infants younger than six months.

The purpose of this study is to evaluate whether the Alive \& Thrive intervention package, consisting of interpersonal counselling and community mobilisation activities, can increase the exclusive breastfeeding rate among infants younger than six months to at least 50% using a cluster randomised design.

Conditions

  • Breast Feeding
  • Breast Feeding, Exclusive

Interventions

BEHAVIORAL

A&T infant and young child feeding intervention

1. Interpersonal communication delivered by community workers and volunteers during home visits and at monthly mother's group meetings to: * Increase mother's knowledge about optimal breastfeeding and its benefits * Increase mother's self-efficacy related to breastfeeding * Improve mother's perceptions about social norms relating to breastfeeding 2. Community mobilisation activities to: \- Raise awareness of the benefits of optimal breastfeeding among opinion leaders, and family members, and increase the support they provide to breastfeeding mothers 3. Enhanced training of government health workers in infant and young child feeding to: * Improve their ability to support mothers and provide timely information about infant feeding

Sponsors & Collaborators

  • FHI 360

    collaborator OTHER

  • Centre Muraz

    collaborator OTHER

  • AFRICSanté

    collaborator OTHER

  • London School of Hygiene and Tropical Medicine

    lead OTHER

Principal Investigators

  • Veronique Filippi · London School of Hygiene and Tropical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • Burkina Faso

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02435524 on ClinicalTrials.gov